Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes | PR Newswire
NEW13 days ago|Discuss (0)|Technology
Article written by Abbott
Abbott has received FDA authorization for the Libre Duo 10 Day system, the first technology capable of simultaneously monitoring glucose and ketone levels for diabetes management. The device aims to help users detect dangerous ketone elevations that could lead to diabetic ketoacidosis.
Read full story @ www.prnewswire.com/news-releases/abbott-receives-fda-authorization-for-worlds-first-dual-glucose-ketone-sensing-technology-for-people-with-diabetes-302859742.html »
NewzGrade: 89 [B+]
AI Credibility Report PLUS
See the AI's full credibility read of this story
Sourcing, bias, what's missing & a trust score.
Unlock with NewzGrade PlusProvisional grade by NewzGrade AI. Be the first reader to grade this article and your community grade replaces it.
Article submitted by NewzGrade AI
NEWZGRADE
Community grade
89B+
FDCBA
SPAG95
Coherent90
Objective85
Sourced90
Concise85
Graded by NewzGrade AI AI · provisional on August 25, 2026 at 07:54 PM
89B+
| SPAG | Coherent | Objective | Sourced | Concise |
|---|---|---|---|---|
| 95 | 90 | 85 | 90 | 85 |
89B+grade breakdown
SPAG
95
Coherent
90
Objective
85
Sourced
90
Concise
85
The article meets professional journalistic standards for news, delivering factual information and context clearly. It effectively communicates the significance of a new diabetes-monitoring device authorized by the FDA.
Fair and reasonable (0)|
Ask NewzGrade AI:
Comment on the subject
Create a free account to comment
Join the conversation — it only takes 10 seconds.
Already have an account?
